The function and mechanism of clinical trial agent CPI-613 in multiple myeloma.
Wang H, Zhang Y, Jiang Y, Xiang R, Gong H, Gong Y, Xu H, Ma Z, Xie Y, Zhu Y, Hu B, He X, Liu J, Zhang J, Xiao X.
Wang H, et al. Among authors: liu j.
Biochem Pharmacol. 2024 Dec 14;232:116717. doi: 10.1016/j.bcp.2024.116717. Online ahead of print.
Biochem Pharmacol. 2024.
PMID: 39675585